Invenire Partners, LP Inotiv, Inc. Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Inotiv, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 95,000 shares of NOTV stock, worth $362,900. This represents 100.0% of its overall portfolio holdings.
Number of Shares
95,000Holding current value
$362,900% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding NOTV
# of Institutions
57Shares Held
4.27MCall Options Held
13.1KPut Options Held
21.3K-
Vanguard Group Inc Valley Forge, PA1.05MShares$4.02 Million0.0% of portfolio
-
Vantage Point Financial LLC Lisle, IL337KShares$1.29 Million0.75% of portfolio
-
Kpp Advisory Services LLC Louisville, KY275KShares$1.05 Million0.27% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN268KShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA251KShares$958,4180.0% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $97.8M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...